{"id":"W2556521065","doi":"10.1016/j.jtho.2016.11.2218","title":"A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non–Small Cell Lung Cancer","year":2016,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Trametinib; Pemetrexed; Medicine; KRAS; Docetaxel; Internal medicine; Oncology; Lung cancer; Tolerability; Rash; MEK inhibitor; Chemotherapy; Cancer; Adverse effect; Colorectal cancer; MAPK/ERK pathway; Cisplatin; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000552664,0.0001929158,0.0007140245,0.0003157991,0.00005575199,0.000009654863,0.000118662,0.00008021169,0.0002421599],"category_scores_gemma":[0.0001923386,0.00009500319,0.00008669524,0.0003357819,0.00004127766,0.0001692689,0.00002535801,0.0002494203,0.000003366108],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001459749,"about_ca_system_score_gemma":0.002004815,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000412119,"about_ca_topic_score_gemma":0.0002320767,"domain_scores_codex":[0.9981958,0.0001923521,0.0006844558,0.0002331682,0.000393275,0.0003009235],"domain_scores_gemma":[0.9980473,0.0002624441,0.0007766707,0.0001855064,0.0005406047,0.0001874559],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02923783,0.01840757,0.2138039,0.0001190395,0.00062028,0.0005839381,0.004422647,0.0001209422,0.001316625,3.806142e-7,0.0002130122,0.7311538],"study_design_scores_gemma":[0.344678,0.1664731,0.4684545,0.002263787,0.007533922,0.0001614662,0.006295744,0.0004633173,0.001593128,0.0000175386,0.001538743,0.0005267926],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962198,0.000470425,0.0003134494,0.0007331783,0.0003772121,0.001382919,0.00001774776,0.000009126132,0.0004761571],"genre_scores_gemma":[0.9914129,0.00006818547,0.0070965,0.0001778447,0.0001426562,0.00009792258,0.000002834276,0.00002932114,0.0009717892],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7306271,"threshold_uncertainty_score":0.3874118,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03428390638763269,"score_gpt":0.4956979824656118,"score_spread":0.4614140760779791,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}